• What We Do
  • Technology
  • Products
  • Partnerships
Press Releases

Press Releases

Press releases

Evogene Stock to be Traded in the TA-100, one of the Leading Indices in theTel-Aviv Stock Exchange

13/12/2012

Evogene Ltd. (TASE: EVGN), a leading developer of improved plant traits for the food, feed and biofuel industries, is to be traded in the TA-100 index as of December 16, 2012, in accordance with the Tel Aviv Stock Exchange (TASE) recent announcement.

The TA-100 Index is one of the TASE's leading stock market indices, consisting of the 100 companies with the highest market capitalization listed on Tel Aviv. 

For more details please see announcement by TASE

Openning Ceremony

 - XXX -

About Evogene

Evogene is a world leading discoverer and developer of improved plant traits through the use of integrated plant genomics. Combining proprietary state-of-the-art computational genomic technologies with advanced breeding methods, the company’s discovery infrastructure provides a complete solution for plant trait improvement to its four market focused operating divisions: Yield and abiotic stress, Biotic stress, Ag-chemicals and Biofuels. In addition to its internal programs, Evogene is collaborating with world leading seed companies to introduce its improved plant traits into key commercial crops under milestone and royalty bearing agreements. Evogene, listed for trading on the Tel Aviv Stock Exchange (TASE: EVGN), is headquartered in Rehovot, with field operations in Israel, Brazil and Argentina. For additional information, please visit Evogene’s website at www.evogene.com

This press release contains "forward-looking statements" relating to future events. These statements may be identified by words such as "may",  “expects”,  "intends", “anticipates”, “plans”, “believes”, “scheduled”, “estimates” or words of similar meaning. Such statements are based on current expectations, estimates, projections and assumptions, describe opinions about future events, involve certain risks and uncertainties which are difficult to predict and are not guarantees of future performance. Therefore, actual future results, performance or achievements of Evogene may differ materially from what is expressed or implied by such forward-looking statements due to a variety of factors, many of which beyond Evogene's control, including, without limitation, those risk factors contained in Evogene’s reports filed with the Israeli Securities Authority. Evogene disclaims any obligation or commitment to update these forward-looking statements to reflect future events or developments or changes in expectations, estimates, projections and assumptions.

Press releases for 2012